Page last updated: 2024-08-23

idarubicin and bilirubin

idarubicin has been researched along with bilirubin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Baccarani, M; Baraldo, M; Damiani, D; Ermacora, A; Fanin, R; Furlanut, M; Michieli, M; Pea, F; Russo, D; Zaja, F1
Dada, R; Galm, O; Gassler, N; Jost, E; Osieka, R; Wilop, S1
Bonkovsky, HL; D'Agostino, RB; Hundley, WG; Jordan, JH; Lamar, ZS; Meléndez, GC; Poole, LB; Porosnicu, M; Vera, T; Whitlock, MC1

Trials

1 trial(s) available for idarubicin and bilirubin

ArticleYear
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia.
    Leukemia, 1998, Volume: 12, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Chemotherapy, Adjuvant; Creatinine; Cyclosporine; Cytarabine; Feasibility Studies; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Treatment Outcome

1998

Other Studies

3 other study(ies) available for idarubicin and bilirubin

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Successful treatment of hepatic encephalopathy in a patient with acute lymphoblastic leukemia.
    Acta haematologica, 2009, Volume: 122, Issue:4

    Topics: Adult; Alanine Transaminase; Ammonia; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Bilirubin; Cyclophosphamide; Dexamethasone; Female; Hepatic Encephalopathy; Humans; Idarubicin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vincristine

2009
Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After Chemotherapy.
    The American journal of cardiology, 2015, Dec-01, Volume: 116, Issue:11

    Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Bilirubin; Breast Neoplasms; Daunorubicin; Doxorubicin; Female; Hematologic Neoplasms; Humans; Idarubicin; Male; Middle Aged; Oxidative Stress; Retrospective Studies; Stroke Volume; Ventricular Dysfunction, Left

2015